Loading...
Response to tyrosine kinase inhibitors in myeloid neoplasms associated with PCM1-JAK2, BCR-JAK2 and ETV6-ABL1 fusion genes
Schwaab, J Naumann, N Luebke, J Jawhar, M Somervaille, Tim CP Williams, Mark S Frewin, R Jost, PJ Lichtenegger, FS La Rosee, P
Schwaab, J
Naumann, N
Luebke, J
Jawhar, M
Somervaille, Tim CP
Williams, Mark S
Frewin, R
Jost, PJ
Lichtenegger, FS
La Rosee, P
Citations
Altmetric:
Abstract
Description
Date
2020
Publisher
Collections
Files
Loading...
From UNPAYWALL
Adobe PDF, 1.79 MB
Keywords
Type
Article
Citation
Schwaab J, Naumann N, Luebke J, Jawhar M, Somervaille TCP, Williams MS, et al. Response to tyrosine kinase inhibitors in myeloid neoplasms associated with PCM1-JAK2, BCR-JAK2 and ETV6-ABL1 fusion genes. Am J Hematol. 2020.